Brandinium

Trademark search for:

LUMIRATEK

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-02-22 — Application filed
  • 2016-10-01 — Sn assigned for sect 66a appl from ib
  • 2016-10-06 — Application filed
  • 2016-10-06 — Assigned to examiner
  • 2016-10-11 — Application filed
  • 2016-10-12 — Final disposition recorded
  • 2016-10-13 — Office action issued
  • 2016-10-30 — Teas revoke/app/change addr of atty/dom rep received
  • 2016-10-30 — Attorney/dom.rep.revoked and/or appointed
  • 2016-11-03 — Office action issued
  • 2016-11-03 — Office action issued
  • 2016-11-18 — Office action issued
  • 2017-04-28 — Office action issued
  • 2017-04-28 — Correspondence received in law office
  • 2017-04-29 — Teas/email correspondence entered
  • 2017-05-01 — Approved for pub - principal register
  • 2017-05-17 — Notification of notice of publication e-mailed
  • 2017-06-06 — Published for opposition
  • 2017-06-06 — Official gazette publication confirmation e-mailed
  • 2017-07-07 — Restriction of holder's right of disposal received
  • 2017-07-19 — Limitation from the ib examined, no action is needed
  • 2017-08-22 — Registered-principal register
  • 2017-11-22 — Final disposition recorded
  • 2017-12-06 — Final disposition recorded
  • 2017-12-06 — Final disposition recorded
  • 2017-12-22 — Final disposition recorded
  • 2019-12-20 — New representative at ib received
  • 2021-07-03 — Restriction of holder's right of disposal received
  • 2021-07-13 — Limitation from the ib examined, no action is needed
  • 2022-08-22 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2024-03-08 — Cancelled section 71
  • 2024-03-08 — Final status recorded
  • 2024-11-09 — Total invalidation of reg ext protection created
  • 2024-11-22 — Change of owner received from ib
  • 2024-11-26 — Generic madrid transaction created
  • 2024-11-26 — Generic madrid transaction sent to ib
  • 2024-12-21 — Total invalidation processed by the ib

Owner Information

Roche Diagnostics International AG
CH
LUMIRADX INTERNATIONAL LTD
GB
LUMIRADX INTERNATIONAL LTD
GB
LUMIRADX INTERNATIONAL LTD
GB

Correspondent

Timothy M. Kenny Norton Rose Fulbright US LLP
98 San Jacinto Boulevard, Suite 1100
c/o Trademark Docketing Dept.
Austin, TX 78701-4255

Filing Details

Filing Date:
2016-02-22
Status Date:
2024-03-08
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.